Today is Wednesday 03-Sep-14 02:56:37 EDT

Frequently Asked Questions

06/18/09

Research Study Will Compare Two Treatments for Lung Cancer


Research Study Will Compare Two Treatments for Lung Cancer
News and Announcements
SAINT LOUIS - Saint Louis University researchers are participating in a clinical trial comparing two standard treatments for early-stage NSCLC (Non-Small Cell Lung Cancer), the most common form of lung cancer.

The STARS (Stereotactic Radiosurgery vs. Surgery) trial will compare the three-year survival rate of patients who undergo a lobectomy, a surgical procedure to remove the tumor, versus CyberKnife treatment, a unique stereotactic body radiotherapy technique that precisely tracks and focuses the radiation on the tumor.

"Surgery is the current gold standard treatment for Stage I NSCLC. However, there are research reports that describe similar survival rates of operable patients treated with the CyberKnife," said John Dombrowski, M.D., Ph.D., assistant professor of radiation oncology at Saint Louis University School of Medicine.

Read More...


Previous page: Walking Map
Next page: For Patients


News from CyberKnife

 1  8   

06/18/09
News and Announcements
Research Study Will Compare Two Treatments for Lung Cancer
+ details

Advances in Technology

Advanced Pulmonary Technology
+ details
Magnetoencephalography (MEG)
+ details
64-Slice PET/CT
+ details
Advanced MRI Technology
+ details
superDimension Technology
+ details